Morgan Stanley Investing Cash Flow increased by 50.7% to -$6.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.1%, from -$5.03B to -$6.60B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -3.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$15.15B | -$15.31B | $158.00M | -$8.53B | -$4.16B | $0.00 | -$1.04B | $6.24B | $517.00M | -$8.80B | $1.05B | -$13.67B | -$6.70B | -$10.15B | -$5.03B | -$17.67B | -$10.68B | -$13.40B | -$6.60B |
| QoQ Change | — | — | -1.0% | +101.0% | <-999% | +51.2% | +100.0% | — | +699.5% | -91.7% | <-999% | +112.0% | <-999% | +51.0% | -51.6% | +50.4% | -251.1% | +39.6% | -25.5% | +50.7% |
| YoY Change | — | — | — | — | — | +72.5% | +100.0% | -758.9% | +173.2% | +112.4% | — | +201.2% | -319.0% | <-999% | -15.3% | -577.6% | -29.3% | -59.4% | -32.0% | -31.1% |